Affiliation: University of Genoa
- Targeted therapy for allergic asthma: predicting and evaluating response to omalizumabFrancesco Tarantini
Pulmunologist, PhD Student, DIMI University of Genoa, Allergy and Respiratory Diseases, Padiglione Maragliano, Largo R Benzi, 16132 Genova, Italy
Expert Rev Clin Immunol 3:463-7. 2007..The results established that it is difficult to predict which patients will gain most benefit from treatment, according to pretreatment baseline characteristics...
- Specific immunotherapy for respiratory allergy: state of the art according to current meta-analysesEnrico Compalati
Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Genoa, Italy
Ann Allergy Asthma Immunol 102:22-8. 2009..To evaluate the efficacy of allergen specific immunotherapy in the treatment of allergic asthma and rhinitis as derived by the available meta-analyses...
- Clara cell 16 protein in COPD sputum: a marker of small airways damage?Fulvio Braido
Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Pad Maragliano, Largo R Benzi, 10 16132 Genova, Italy
Respir Med 101:2119-24. 2007..This protein has never been related to patients' lung function tests, blood gases parameters and diseases severity...
- Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trialsMartin Penagos
Allergy and Respiratory Diseases, Department of Internal Medicine, University of Genoa, Italy
Ann Allergy Asthma Immunol 97:141-8. 2006..To evaluate the efficacy of sublingual immunotherapy (SLIT) in the treatment of allergic rhinitis in children...